Zobrazeno 1 - 10
of 723
pro vyhledávání: '"non-Hodgkin lymphomas"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionPeripheral T-cell lymphomas (PTCLs) have poor outcomes in the relapsed/refractory (R/R) setting. In this study, we evaluated the efficacy of dexamethasone, L-asparaginase, ifosfamide, carboplatin, and etoposide (DL-ICE) chemotherapy follo
Externí odkaz:
https://doaj.org/article/06048182c18f4e7cb729df15909255e9
Lymphome T hépato-splénique et maladie de Crohn [Hepato-splenic T-cell lymphoma and Crohn’s disease]
Autor:
Mouna Gourine, Samir Saadi, Rafik Elaoufi, Mohammed Arrar, Anwer Cherrak, Mohammed Amine Chami
Publikováno v:
Journal de la Faculté de Médecine d'Oran, Vol 1, Iss 3 (2024)
Résumé Introduction - Le lymphome T hépato-splénique (LTHS) est un lymphome extra-ganglionnaire rare appartenant au groupe des lymphomes malins non hodgkiniens (LMNH). Ce lymphome, dont les manifestations cliniques sont systémiques, comporte des
Externí odkaz:
https://doaj.org/article/3abf8c57fe194295870178afe0506ff5
Autor:
Abu-Alghayth, Mohammed H. a, Abalkhail, Adil b, Hazazi, Ali c, d, Alyahyawi, Yara e, Abdulaziz, Osama f, Alsharif, Abdulaziz f, Nassar, Somia A. g, h, Omar, Bashir Ibrahim A. i, Alqahtani, Sultan F. j, Shmrany, Humood Al g, ⁎, Khan, Farhan R. i, ⁎
Publikováno v:
In Pathology - Research and Practice February 2025 266
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 2, Pp 332-348 (2024)
Hematologists, geneticists, and clinicians came to a multidisciplinary agreement on the classification of lymphoid neoplasms that combines clinical features, histological characteristics, immunophenotype, and molecular pathology analyses. The current
Externí odkaz:
https://doaj.org/article/f74eb40d44d04eb4b42a27622ff33c24
Autor:
Irina V. Poddubnaya
Publikováno v:
Современная онкология, Vol 25, Iss 4, Pp 417-420 (2023)
Non-Hodgkin lymphomas are a heterogeneous group of hematological malignancies, the vast majority of which are B-cell tumors. Standard immunochemotherapy with anti-CD20 monoclonal antibodies is effective as the first-line therapy in treating these lym
Externí odkaz:
https://doaj.org/article/45b7ca9e8f1244f4a004a6720c79757b
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-7 (2023)
Abstract Purpose To investigate the clinical features and survival outcomes of primary gastrointestinal non-Hodgkin lymphomas (PGINHL) in pediatric and adolescent population, we conducted a population-based cohort study. Methods All pediatric and ado
Externí odkaz:
https://doaj.org/article/8acaf4e795c14afeb5613ba2d64af169
Autor:
Yang Li, Yang Liu, Keyan Yang, Ling Jin, Jing Yang, Shuang Huang, Ying Liu, Bo Hu, Rong Liu, Wei Liu, Ansheng Liu, Qinlong Zheng, Yonghong Zhang
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Chimeric antigen receptor (CAR)-T cell therapy has been used to treat pediatric refractory or relapsed mature B-cell non-Hodgkin lymphoma (r/r MB-NHL) with significantly improved outcomes, but a proportion of patients display no r
Externí odkaz:
https://doaj.org/article/90779d56bb0c4be9b8ed964e25f114c6
Autor:
Victor Tomacinschii, Adrian Mosquera Orgueira, Carlos Aliste Santos, Maria Robu, Sanda Buruiana, Maximo Francisco Fraga Rodriguez
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Next generation sequencing (NGS) is a technology that broadens the horizon of knowledge of several somatic pathologies, especially in oncological and oncohematological pathology. In the case of NHL, the understanding of the mechanisms of tumorigenesi
Externí odkaz:
https://doaj.org/article/d47864ff8c8b43699c65ac818dc39a1b
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 16-21 (2022)
In given article non-Hodgkin lymphomas epidemiology, main attempts of gastrointestinal tract (GIT) lymphomas sistematization, basic methods of stomach NHL diagnostics, such as radiologic and endoscopic are described. Also importance of modern endosco
Externí odkaz:
https://doaj.org/article/e8589dec31564092808b55388fdd2ef2
Autor:
E. V. Samochatova, L. N. Schelikhova, M. B. Belogurova, A. V. Schamardina, E. V. Bascharova, D. V. Litvinov, N. V. Myakova, L. G. Fechina, O. P. Chlebnikova, E. V. Inuschkina, O. V. Riskal, P. Z. Schammasov, I. M. Yunusova, S. Yu. Umnova, D. M. Konovalov, A. G. Talalaev, J. V. Roumiantseva, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 4-14 (2022)
Therapy results of 61 patients (children and adolescents, 2—17 years of age; a median — 8.76 years) with B-cells non-Hodgkin lymphomas III—IV stage and B-cell acute leukemia (B-NHL/B-ALL), treating according to protocol with polichemotherapy an
Externí odkaz:
https://doaj.org/article/483bc1441ecd4784874b8cf5dccf3b60